{"id":"ergoloid","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ERGOLOID","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:12:08.473766+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:12:14.178211+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ERGOLOID","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:12:14.395693+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Adrenergic receptor alpha antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:12:15.509760+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2311030/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:12:15.175768+00:00"}},"_dailymed":{"setId":"1344cf98-7d79-4ab4-9a63-2e632d9afbd4","title":"ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]"},"_scrapedAt":"2026-03-28T00:32:55.257Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:12:16.864311+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT05030129","phase":"PHASE2","title":"ERG/5-HTP in Fragile X Syndrome (FXS)","status":"COMPLETED","sponsor":"Elizabeth Berry-Kravis","startDate":"2021-10-07","conditions":"Fragile X Syndrome","enrollment":15},{"nctId":"NCT01475578","phase":"PHASE2","title":"Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)","status":"COMPLETED","sponsor":"Sinphar Pharmaceutical Co., Ltd","startDate":"2002-03","conditions":"Vascular Dementia","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL2311030"},"_approvalHistory":[],"publicationCount":48,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"approved","brandName":"ERGOLOID","genericName":"ERGOLOID","companyName":"","companyId":"","modality":"","firstApprovalDate":"1953","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:12:16.864311+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}